³í¹®½ÇÀû

Áö¿ø°úÁ¦º° :
¿¬µµº° :
¸ðµÎº¸±â
Influence of P-glycoprotein modulators on cardiac uptake, metabolism, and effects of idarubicin()
Pharm Res, 2001, 18/1535~1541 [LINK]
2003-International
Frequency of cytochrome P450 2C9 mutant alleles in a Korean population()
Br J Clin Pharmacol, 2001, 51/277~280 [LINK]
2003-International
Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol()
Br J Clin Pharmacol, 2001, 51/45~52 [LINK]
2003-International
Clinical Pharmacogenomics: A Principle for tailored pharmacotherapy()
J Asthma Allergy Clin Immunol, 2001, 21/716~718 [LINK ]
2003-International
In vivo pharmacokinetics of pyribenzoxim in rats()
Pest Manag Sci, 2001, 57/1155~1160 [LINK]
2003-International
Simultaneous Determination of Furathiocarb and its Metabolites in Biological Tissues using High Performance Liquid Chromatography and Post-Column Derivatization()
Chromatographia, 2001, 53/687~690 [LINK ]
2003-International
Floss.Mutational Analysis and Reconstituted Expression of the Biosynthetic Genes Involved in the Formation of 3-Amino-5-hydroxybenzoic Acid, the Starter Unit of Rifamycin Biosynthesis in Amycolatopsis mediterranei S699.()
J Biol Chem, 2001, 276/12546~12555 [LINK ]
2003-International
Microcystin-induced down-regulation of lymphocyte functions through reduced IL-2 mRNA stability.()
Toxicol Lett, 2001, 122/21~31 [LINK]
2003-International
Association between TNF-¥á promoter polymorphism and Helicobacter pylori cagA subtype infection.()
J Clin Pathol, 2001, 54/703~706 [LINK ]
2003-International
The -238 tumor necrosis factor-¥á promoter polymorphism is associated with decreased susceptibility to cancers.()
Cancer Lett, 2001, 166/41~46 [LINK]
2003-International